Canada markets closed

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.26000.0000 (0.00%)
At close: 04:00PM EDT
3.3100 +0.05 (+1.53%)
After hours: 07:43PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-6,002
-5,339
-9,926
-19,322
-9,738
Depreciation & amortization
101
111
114
91
93
Stock based compensation
596
686
556
497
43
Change in working capital
358
-472
-1,661
-28
1,877
Accounts Payable
163
28
-783
-411
1,101
Other working capital
-4,947
-5,014
-10,914
-18,805
-7,744
Net cash provided by operating activites
-4,947
-5,014
-10,912
-18,762
-7,725
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-2
-43
-19
Net cash used for investing activites
0
0
-2
-43
-19
Cash flows from financing activities
Common stock issued
-
-
0
24,070
50,894
Other financing activites
-
-
-
-977
-2,442
Net cash used privided by (used for) financing activities
-
-
0
23,093
48,452
Net change in cash
-4,947
-5,014
-10,914
4,288
40,708
Cash at beginning of period
40,850
42,445
53,359
49,071
8,363
Cash at end of period
35,903
37,431
42,445
53,359
49,071
Free Cash Flow
Operating Cash Flow
-4,947
-5,014
-10,912
-18,762
-7,725
Capital Expenditure
-
-
-2
-43
-19
Free Cash Flow
-4,947
-5,014
-10,914
-18,805
-7,744